Study Name:
LYT-100 in Post-acute COVID-19 Respiratory Disease
Targeted Disease(s):
COVID-19
Purpose of Study:
To evaluate the safety and efficacy of LYT-100 with post-acute COVID-19 respiratory complications who were treated with, but no longer require mechanical ventilation, extracorporeal membrane oxygenation, non-invasive ventilation (eg CPAP or BiPAP), high-flow nasal oxygen therapy, or combination thereof.
Study Dates:
December 11, 2020 - December 30, 2021
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Lead Institution:
USC
Funding Source:
Puretech
ClinicalTrails.gov Identifier:
NCT04652518